Abscopal Effect
Showing 51 - 75 of >10,000
Hepatocellular Carcinoma Trial in Seoul (AtezoBev with combined radiotherapy)
Not yet recruiting
- Hepatocellular Carcinoma
- AtezoBev with combined radiotherapy
-
Seoul, Korea, Republic ofSeverance hospital
Jun 9, 2023
Metastatic Cancer Trial in Rochester (Keytruda Injectable Product, Yervoy Injectable Product, Cytoxan)
Recruiting
- Metastatic Cancer
- Keytruda Injectable Product
- +4 more
-
Rochester, MichiganAscension Providence Rochester Hospital
Jun 15, 2022
Cohort 1 : Metastatic Non Small Cell Lung Cancer, Cohort 2 : Metastatic Bladder Cancer, Cohort 3 : Metastatic Renal Cell
Not yet recruiting
- Cohort 1 : Metastatic Non Small Cell Lung Cancer
- +3 more
- Atezolizumab 60 MG/1 ML Intravenous Solution [TECENTRIQ]
- +2 more
-
Dijon, Bourgogne, FranceCentre Georges François Leclerc (CGFL)
Feb 18, 2022
Cutaneous Melanoma, Stage III, Cutaneous Melanoma, Stage IV Trial in Tampa (IFx-Hu2.0)
Completed
- Cutaneous Melanoma, Stage III
- Cutaneous Melanoma, Stage IV
- IFx-Hu2.0
-
Tampa, FloridaH. Lee Moffitt Cancer Center
Aug 5, 2022
Mesothelioma; Lung Trial in Toronto (Varying Doses of Background and Boost RT)
Active, not recruiting
- Mesothelioma; Lung
- Varying Doses of Background and Boost RT
-
Toronto, Ontario, CanadaPrincess Margaret Hospital, University Health Network
Oct 25, 2022
Metastatic Prostatic Adenocarcinoma Trial in Lancaster, Rochester (Opdivo Injectable Product, Yervoy Injectable Product,
Completed
- Metastatic Prostatic Adenocarcinoma
- Opdivo Injectable Product
- +3 more
-
Lancaster, California
- +1 more
Jun 15, 2022
Esophageal Tumor, Metastatic Esophageal Squamous Cell Carcinoma Trial in Taipei (Avelumab)
Enrolling by invitation
- Esophageal Tumor
- Metastatic Esophageal Squamous Cell Carcinoma
-
Taipei, TaiwanNational Taiwan University Hospital, Taiwan
Sep 6, 2021
Head and Neck Squamous Cell Carcinoma Trial in Seoul (Durvalumab Plus Tremelimumab)
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- Durvalumab Plus Tremelimumab
-
Seoul, Korea, Republic ofDepartment of Medicine, Samsung Medical Center, Sungkyunkwan Uni
Aug 8, 2021
Urinary Bladder Tumors Trial run by the NCI (Durvalumab, Vicineum)
Recruiting
- Urinary Bladder Neoplasms
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Prospective Primary Human Lungcancer Organoids to Predict
Recruiting
- Lung Cancer
- Organoids
-
Heerlen, Netherlands
- +1 more
Feb 22, 2022
Esophageal Squamous Cell Carcinoma, Esophageal Cancer, Metastatic Esophageal Squamous Cell Carcinoma Trial in Shanghai
Recruiting
- Esophageal Squamous Cell Carcinoma
- +2 more
- LDRT+CFRT
- +2 more
-
Shanghai, China
- +1 more
Aug 3, 2023
Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8 Trial in United States
Recruiting
- Metastatic Renal Cell Carcinoma
- +3 more
- Avelumab
- +7 more
-
Danville, Illinois
- +4 more
Jul 29, 2022
Breast Cancer, Radiation Toxicity Trial in Ghent (Radiotherapy)
Completed
- Breast Cancer
- Radiation Toxicity
- Radiotherapy
-
Ghent, Oost-Vlaanderen, Belgium
- +1 more
Jan 3, 2023
Head and Neck Squamous Cell Carcinoma, Metastases, Immunotherapy Trial in Beijing (Sintilimab, SBRT, Platinum based chemo)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- +3 more
- Sintilimab
- +2 more
-
Beijing, ChinaCancer hospital, Chinese Academy of Medical Sciences
Nov 16, 2021
Non-Small Cell Carcinoma of Lung, TNM Stage 4 Trial in Heerlen, Maastricht (Radiotherapy)
Recruiting
- Non-Small Cell Carcinoma of Lung, TNM Stage 4
- Radiotherapy
-
Heerlen, Netherlands
- +2 more
Apr 13, 2021
Cancer Patients Trial in Jinan (Low-dose radiotherapy combined with conventional fractionated radiotherapy)
Recruiting
- Cancer Patients
- Low-dose radiotherapy combined with conventional fractionated radiotherapy
-
Jinan, In Shandong Province, ChinaThe First Affiliated Hospital of Shandong First Medical Universi
Jun 7, 2023
Multiple Primary Lung Cancer Trial (Stereotactic Ablation Radiotherapy, Sintilimab)
Not yet recruiting
- Multiple Primary Lung Cancer
- Stereotactic Ablation Radiotherapy
- Sintilimab
- (no location specified)
Apr 8, 2021
HCC Trial in Hong Kong (procedure, radiation, drug)
Active, not recruiting
- HCC
- TACE
- +2 more
-
Hong Kong, Hong KongDepartment of Clinical Oncology
Oct 24, 2022
Solid Tumor, Advanced Cancer, Metastatic Cancer Trial in Tampa, Durham (MEM-288 Intratumoral Injection)
Recruiting
- Solid Tumor
- +9 more
- MEM-288 Intratumoral Injection
-
Tampa, Florida
- +1 more
Jun 27, 2022
Head and Neck Tumor Trial in Ghent, Leuven, Namur (Stereotactic body radiotherapy)
Terminated
- Head and Neck Neoplasm
- Stereotactic body radiotherapy
-
Ghent, Oost-Vlaanderen, Belgium
- +2 more
Feb 16, 2021
Basal Cell Carcinoma Trial in Cleveland (ALA, PDT)
Recruiting
- Basal Cell Carcinoma
- ALA
- PDT
-
Cleveland, OhioCleveland Clinic, Case Comprehensive Cancer Center
Mar 2, 2022
Renal Cancer Metastatic Trial in Reggio Emilia (Nivolumab)
Completed
- Renal Cancer Metastatic
-
Reggio Emilia, ItalyStruttura Complessa di OncologiaIRCCS- Istituto in Tecnologie Av
May 1, 2022
Myeloma, Multiple, Myeloma-Multiple Trial run by the NCI (Avelumab, External beam radiotherapy)
Terminated
- Myeloma, Multiple
- Myeloma-Multiple
- Avelumab
- External beam radiotherapy
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 19, 2021
Squamous Cell Carcinoma of the Head and Neck, Paclitaxel, Carboplatin Trial in Amiens (GCP intratumoral catheter)
Not yet recruiting
- Squamous Cell Carcinoma of the Head and Neck
- +3 more
- intratumoral catheter
-
Amiens, Picardie, FranceCHU Amiens Picardie
Apr 26, 2023